Day: December 16, 2025

DURHAM, N.C., Dec. 16, 2025 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it has entered into a credit facility with Avenue Venture Opportunities Fund II, L.P., a fund of Avenue Capital Group, providing up to $77.5 million in principal amount of new financing. The credit agreement, which has a term of four years, includes an initial tranche of $40 million fully funded at close, and an additional two tranches of up to an aggregate of $37.5 million available to Humacyte, subject to the satisfaction of certain revenue, regulatory approvals, liquidity conditions and, in the case of the third tranche, lender approvals. Proceeds from the initial $40 million tranche have been used...

2025 milestones reinforce EagleNXT’s growing role in global aerial intelligence markets and establish a strong foundation for scale in 2026 WICHITA, Kan., Dec. 16, 2025 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (dba, EagleNXT) (the “Company” or “EagleNXT”) (NYSE: UAVS) a leading provider of full stack drone, sensors and software solutions for customers worldwide in the commercial and government verticals, provides a recap of its operational and strategic achievements in 2025 and outlines key priorities and expected growth drivers for 2026. The Company’s 2025 performance reflects continued momentum in defense adoption, commercial innovation and agronomic research, global service and support expansion, and enhancements to its capital structure designed to support scale. “EagleNXT experienced 2025 as a defining year, which we...

BOCA RATON, Fla., Dec. 16, 2025 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announces that in order to assist the Company in managing near-term working capital requirements, the Company and Jim Cacioppo, the Company’s Chairman and Chief Executive Officer, have agreed to certain amendments to Mr. Cacioppo’s employment agreement (collectively, the “Employment Agreement Amendments”). All of the Employment Agreement Amendments were approved on behalf of the Company by the independent directors of the Company. Pursuant to the Employment Agreement Amendments, Mr. Cacioppo, has agreed to receive the $1,050,000 annual cash bonus that would otherwise have been paid to him on or before March 15, 2026, and the options to purchase 3,000,000...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES  HALIFAX, Nova Scotia, Dec. 16, 2025 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing healthcare services company, is pleased to announce the launch of a new Care Management division focused on strengthening care delivery, outcomes and partnerships across the health care continuum. The Company has appointed Breanne Muchemore as Vice President, Care Management, to lead this new division. Ms. Muchemore brings extensive leadership experience in care coordination, value-based care strategies, and health system partnerships, with a focus on improving outcomes and advancing patient-centered models of care. She will guide the development of Nova Leap’s Care Management framework and oversee its initial...

Peer To Peer Network’s AI division, PTOP Intelligence Labs, accelerates contract fulfillment via strategic partnership Takeaways:Peer To Peer Network, through its AI division, PTOP Intelligence Labs, secured a strategic technology partnership to accelerate the deployment of its Tier-1 AI investor-relations solution. PTOP Intelligence Labs is actively onboarding Tier-1 BETA customers while achieving commercialization and revenue generation. AI Division to boost IR solutions capability by integrating AI workflow agentsCAMBRIDGE, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) — Peer To Peer Network, Inc. (OTC: PTOP), the inventor of the digital business card, announces a Strategic Technology Partnership and new customer onboarding.Through its AI division, PTOP Intelligence Labs, the Company has partnered with a specialized AI development...

JACKSONVILLE, Fla., Dec. 16, 2025 (GLOBE NEWSWIRE) — Regency Centers Corporation (“Regency Centers” or “Regency”) (Nasdaq: REG) today announced the election of Mark J. Parrell to its Board of Directors (the “Board”), effective January 1, 2026. With the addition of Mr. Parrell as an independent director, Regency will expand the size of its Board to twelve directors. “We are delighted to welcome Mark to our Board,” said Martin E. “Hap” Stein, Jr., Executive Chair of Regency Centers. “His proven leadership and extensive experience in the real estate business, including as both CEO and CFO of a sector-leading S&P 500 commercial residential real estate company, will be invaluable as we continue to execute our strategy and create long-term value for our shareholders.” Mr. Parrell currently serves as President, Chief Executive Officer,...

ROCHESTER, NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) — Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec Optics” or the “Company”), a leading provider of technology products to defense, biomedical, communications, and consumer end-market leaders, today announced it has received a new order to make optics that can enable both day and nighttime readable AR displays. Syntec’s lightweight, high-clarity optics will enable US warfighters to maintain focus in high-stress, long-duration combat. VP of business development and delivery, Matt Carey, said, “It is great to have Syntec’s innovations in the redefined battlefield as part of the US domestic manufacturing supply chain.” Dean Rudy, CFO of Syntec Optics, said, “Syntec is continuing to prioritize its investments in next-generation products that allow...

Investeringsforeningen Nordea Invest meddeler følgende hovedbegivenheder i 2026:10. marts 2026 Årsrapport for 2025 offentliggøres13. april 2026 Ordinær generalforsamling afholdes27. august 2026 Halvårsrapport for 1. halvår 2026 offentliggøresMed venlig hilsenNordea Fund Management, filial af Nordea Funds Oy, Finland Rasmus Eske BruunFilialbestyrer

Supports Development of Phospholipid Radioconjugate (PRC) CLR-225 for the Treatment of Solid Tumors FLORHAM PARK, N.J. and LANSING, Mich., Dec. 16, 2025 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced a multi-year supply agreement with Ionetix Corporation, a leading cyclotron technology innovator and full-service radioisotope manufacturer, for two critical alpha-emitting radioisotopes: Actinium-225 (Ac-225) and Astatine-211 (At-211). Under the agreement, Ionetix will provide Cellectar with a reliable, clinical and commercial-scale supply of cGMP-grade Ac-225 and At-211 to support its drug development programs through clinical trials and into potential commercial launches of...

MediBeacon® TGFRTM System is a first-in-kind product for point of care kidney function assessment Centers of Excellence commercialization in select academic medical centers begins in early 2026NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) — INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, in which INNOVATE owns a 44.7% equity interest, has received approval from the U.S. Food and Drug Administration (FDA) for the next generation MediBeacon® TGFRTM System including the latest TGFRTM Reusable Sensor. The TGFR System enables kidney function assessment at the point of care by measuring the clearance rate of Lumitrace® (relmapirazin), a non-radioactive,...